Publications by authors named "Jose Gomez Codina"

Claim this Profile
S
SEOM-GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025).
Josep Gumà, Natalia Palazón-Carrión, Antonio Rueda-Domínguez, Silvia Sequero, Virginia Calvo, José Gómez-Codina

Clin Transl Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of late toxicities and specific follow-up needs of adolescent and young adult cancer survivors: recommendations from scientific societies in Spain.
Alejandro Pérez Fidalgo, Pilar Alonso, Maitane Andión, Adela Cañete, Erica Collado, José Gómez Codina

Clin Transl Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial.
Sara Fernández-Castillejo, Joan Badia, Luís de la Cruz-Merino, Alejandro Martín Garcia-Sáncho, Fernando Carnicero-González, José Gómez-Codina

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
Lourdes Hontecillas-Prieto, Daniel J García-Domínguez, Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, José Gómez-Codina

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL).
Natividad Martínez-Banaclocha, Francisca Martínez-Madueño, Berta Caballé, Joan Badia, Mar Blanes, Jose Gómez Codina

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study.
Raul Cordoba, Joaquín Sánchez-García, Eva Domingo-Domenech, Javier López Jiménez, Antonio Martínez Pozo, José Gómez Codina

Expert Rev Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
Alejandro Martín García-Sancho, Socorro M Rodríguez-Pinilla, Eva Domingo-Domenech, Fina Climent, Joaquín Sánchez-Garcia, José Gómez Codina

Br J Haematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022).
Josep Gumà, Natalia Palazón-Carrión, Antonio Rueda-Domínguez, Silvia Sequero, Virginia Calvo, José Gómez-Codina

Clin Transl Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital.
Javier Simarro, Gema Pérez-Simó, Nuria Mancheño, Emilio Ansotegui, Carlos Francisco Muñoz-Núñez, José Gómez-Codina

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.
Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, Carlos Jiménez-Cortegana, Fernando Carnicero-González, José Gómez-Codina

Clin Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for -Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients.
Javier Simarro, Gema Pérez-Simó, Nuria Mancheño, Emilio Ansotegui, Carlos Francisco Muñoz-Núñez, José Gómez-Codina

Int J Mol Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.
Carlos Jiménez-Cortegana, Natalia Palazón-Carrión, Alejandro Martin Garcia-Sancho, Esteban Nogales-Fernandez, Fernando Carnicero-González, José Gómez-Codina

J Immunother Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
Eva González-Barca, Francisco Javier Capote, Jose Gómez-Codina, Carlos Panizo, Antonio Salar

Ann Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel).
Fernando Franco, María Guirado, Natividad Martínez-Banaclocha, Josep Gumà, Javier Lavernia, José Gómez-Codina

Curr Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study.
Socorro Maria Rodriguez-Pinilla, Eva Domingo-Domenech, Fina Climent, Joaquin Sanchez, Carlos Perez Seoane, Jose Gomez Codina

Br J Haematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma.
Lucía Pedrosa, Ismael Fernández-Miranda, David Pérez-Callejo, Cristina Quero, Marta Rodríguez, José Gómez-Codina

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Julia González-Rincón, Miriam Méndez, Sagrario Gómez, Juan F García, Paloma Martín, José Gómez-Codina

PLoS One· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).
Dolores Isla, Ramón De Las Peñas, Amelia Insa, Raquel Marsé, Natividad Martínez-Banaclocha, José Gómez-Codina

Lung Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.
Javier Simarro, Rosa Murria, Gema Pérez-Simó, Marta Llop, Nuria Mancheño, José Gómez-Codina

Cancers (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group.
Miriam Méndez, Maria Torrente, Margarita Sánchez-Beato, Julia González-Rincón, Ana Royuela, José Gómez-Codina

Hematol Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years.
Mariano Provencio, Fernando Franco, José Gómez-Codina, Cristina Quero Blanco, Marta Llanos

Leuk Lymphoma· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Samuel Romero, Juan Montoro, Marta Guinot, Luis Almenar, Rafael Andreu, José Gómez-Codina

Leuk Lymphoma· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus.
Pilar Miralles, José Tomás Navarro, Juan Berenguer, José Gómez Codina, Mi Kwon

Med Clin (Barc)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational profile of primary breast diffuse large B-cell lymphoma.
Fernando Franco, Julia González-Rincón, Javier Lavernia, Juan F García, Paloma Martín, José Gómez-Codina

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
Mariano Provencio, Ana Royuela, María Torrente, Marina Pollán, José Gómez-Codina

Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis